Crystal Structure of Von Willebrand Factor (VWF) A1 Domain in Complex with Aptamer ARC1172, An Inhibitor of VWF-Platelet Binding

被引：0
|
作者：
Huang, Ren-Huai [1 ]
Fremont, David [2 ]
Tuley, Elodee A. [1 ]
Diener, John L. [3 ]
Schaub, Robert G. [4 ]
Sadler, J. Evan [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA
[3] Novartis Inst BioMed Res Inc, Cambridge, MA USA
[4] Archemix Corp, Cambridge, MA USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [11] The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease
    Ay, Cihan
    Pabinger, Ingrid
    Kovacevic, Katarina D.
    Gelbenegger, Georg
    Schorgenhofer, Christian
    Quehenberger, Peter
    Jilma-Stohlawetz, Petra
    Sunder-Plassman, Raute
    Gilbert, James C.
    Zhu, Shuhao
    Jilma, Bernd
    Derhaschnig, Ulla
    BLOOD ADVANCES, 2022, 6 (18) : 5467 - 5476
  • [12] OPTIMAL BINDING OF VON-WILLEBRAND-FACTOR (VWF) TO COLLAGEN REQUIRES INCORPORATION OF THE VWF-A3 DOMAIN INTO FULL-LENGTH VWF
    CRUZ, MA
    LEE, JR
    WISE, RJ
    HANDIN, RI
    BLOOD, 1993, 82 (10) : A449 - A449
  • [13] von Willebrand factor variant D1472H has no effect in mice with humanized VWF-platelet interactions
    Lohmeier, Hannah K.
    Slobodianuk, Tricia L.
    Kanaji, Sachiko
    Haberichter, Sandra L.
    Montgomery, Robert R.
    Flood, Veronica H.
    BLOOD ADVANCES, 2020, 4 (17) : 4065 - 4068
  • [14] The A3 domain of vWF regulates the binding of the A1 domain to platelet GPIb
    Obert, B
    Houllier, A
    Meyer, D
    Girma, JP
    THROMBOSIS AND HAEMOSTASIS, 1999, : 495 - 495
  • [15] ARC15105 a potent antagonist of von Willebrand factor (VWF) platelet activation and adhesion
    Siller-Matula, J. M.
    Merhi, Y.
    Tanguay, J-F
    Duerschmied, D.
    McGinness, K. E.
    Pendergrast, S. P.
    Wagner, D. D.
    Schaub, R. G.
    Jilma, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 17 - 18
  • [16] ARC15105 A POTENT ANTAGONIST OF VON WILLEBRAND FACTOR (VWF) PLATELET ACTIVATION AND ADHESION
    Siller-Matula, J. M.
    Merhi, Y.
    Tanguay, J. -F
    Duerschmied, D.
    McGinness, K. E.
    Pendergrast, P. S.
    Wagner, D. D.
    Schaub, R. G.
    Jilma, B.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 25 - 25
  • [17] Hemophilic factor VIII (FVIII) C domain mutations and von Willebrand factor (VWF) binding
    Liu, M
    Nakaya, S
    Thompson, AR
    THROMBOSIS AND HAEMOSTASIS, 1999, : 2 - 2
  • [18] Overlap of collagen 4 and platelet binding sites in VWF A1 domain
    Schlauderaff, A. C.
    Haberichter, S. L.
    Slobodianuk, T. L.
    Morateck, P. A.
    Montgomery, R. R.
    Flood, V. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 94 - 95
  • [19] THE APTAMER BT200 BLOCKS VON WILLEBRAND FACTOR (VWF) AND VWF DEPENDENT PLATELET FUNCTION IN SAMPLES FROM ACUTE STROKE PATIENTS
    Kovacevic, K.
    Buchtele, N.
    Gelbenegger, G.
    Greisenegger, S.
    Gilbert, J. C.
    Zhu, S.
    Jilma, B.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 493 - 493
  • [20] Design and synthesis of vWF TASP, a novel synthetic peptide mimicking the A1 domain of the von Willebrand factor.
    Kovacsovics, T
    Mathieu, S
    Fernandez-Carneado, A
    Grell, D
    Schapira, M
    Spertini, O
    Tuchscherer, G
    Hauert, J
    BLOOD, 2001, 98 (11) : 516A - 516A
12345